Alkeran and Osteoarthritis - a phase IV clinical study of FDA data
Osteoarthritis is found among people who take Alkeran, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Alkeran and have Osteoarthritis. It is created by eHealthMe based on reports of 5,418 people who have side effects when taking Alkeran from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
5,418 people reported to have side effects when taking Alkeran.
Among them, 106 people (1.96%) have Osteoarthritis.
What is Alkeran?
Alkeran has active ingredients of melphalan. eHealthMe is studying from 5,429 Alkeran users for its effectiveness, alternative drugs and more.
What is Osteoarthritis?
Osteoarthritis (a joint disease caused by cartilage loss in a joint) is found to be associated with 3,157 drugs and 2,491 conditions by eHealthMe.
Number of Alkeran and Osteoarthritis reports submitted per year:
Gender of people who have Osteoarthritis when taking Alkeran*:
Age of people who have Osteoarthritis when taking Alkeran *:
Common drugs people take besides Alkeran *:
Common side effects people have besides Osteoarthritis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Alkeran and have Osteoarthritis?Check whether Osteoarthritis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Osteoarthritis and when was it recovered:
Expand to all the drugs that have ingredients of melphalan:
- Osteoarthritis and drugs with ingredients of melphalan (151 reports)
Alternative drugs to, pros and cons of Alkeran:
- Alkeran (5,429 reports)
Common Alkeran side effects:
- Fever: 495 reports
- Diarrhea: 457 reports
- Thrombocytopenia (decrease of platelets in blood): 400 reports
- Pneumonia: 365 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 326 reports
- Pain: 320 reports
Browse all side effects of Alkeran:a b c d e f g h i j k l m n o p q r s t u v w x y z
Osteoarthritis treatments and more:
- Osteoarthritis (85,038 reports)
COVID vaccines that are related to Osteoarthritis:
- Osteoarthritis in Moderna COVID Vaccine
- Osteoarthritis in Pfizer BioNTech Covid Vaccine
- Osteoarthritis in Johnson and Johnson Covid Vaccine
Common drugs associated with Osteoarthritis:
- Humira: 9,485 reports
- Fosamax: 8,826 reports
- Methotrexate: 7,541 reports
- Prednisone: 5,766 reports
- Enbrel: 5,489 reports
- Aspirin: 3,760 reports
- Zometa: 3,452 reports
- Alendronate sodium: 3,078 reports
- Synthroid: 2,892 reports
- Celebrex: 2,879 reports
All the drugs that are associated with Osteoarthritis:
- Osteoarthritis (3,157 drugs)
Common conditions associated with Osteoarthritis:
- Rheumatoid arthritis: 11,790 reports
- Osteoporosis: 7,938 reports
- High blood pressure: 4,401 reports
- Pain: 3,534 reports
All the conditions that are associated with Osteoarthritis:
- Osteoarthritis (2,491 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on melphalan (the active ingredients of Alkeran) and Alkeran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lexapro and Tart Cherry drug interaction - now
- Autoimmune Hepatitis and drugs of ingredients of amlodipine besylate - a second ago
- Nortriptyline Hydrochloride and Renal Cell Carcinoma - 4 seconds ago
- Gabapentin vs. Atacand - 6 seconds ago
- Lidocaine and Pseudomonas Infection - 17 seconds ago
- Creatine Monohydrate and Fever - 25 seconds ago
- Dizziness in Potassium Citrate, how severe and when it was recovered? - 29 seconds ago
- Hetlioz and Tinnitus - 30 seconds ago
- Prednisone and Emphysema - 38 seconds ago
- Calan and Pupil Fixed - 39 seconds ago